Results 81 to 90 of about 93,360 (257)

Ventilation/perfusion SPECT in children: Feasibility, impact on clinical decision‐making and interrater agreement

open access: yesClinical Physiology and Functional Imaging, Volume 45, Issue 4, July 2025.
Abstract Introduction It remains to be established whether it provides any clinical or diagnostic benefits to perform ventilation/perfusion (V/Q) scintigraphy as a single photon emission computed tomography in children. Here, we report our experience with this modality, evaluate its impact on clinical decision‐making and assess its interrater agreement.
Lise Borgwardt   +6 more
wiley   +1 more source

NEONATAL THROMBOCYTOPENIC PURPURA: REPORT OF TWO CASES AND REVIEW OF LITERATURE [PDF]

open access: yesKanem Journal of Medical Sciences, 2018
Introduction: Severe neonatal thrombocytopenia is a hematological emergency that can be due to increased platelet destruction (such as immune-mediated and peripheral platelet consumption) or congenital failure of platelet production.
Abiodun MT, Badejoko B, Oluwafemi RO
doaj  

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

open access: yesHaematologica, 2008
Background From 20 to 50% of patients who survive an acute episode of the acquired form of thrombotic thrombocytopenic purpura relapse but clinical and laboratory markers of recurrence are not well established.Design and Methods In 109 patients enrolled ...
Flora Peyvandi   +15 more
doaj   +1 more source

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

open access: yesHaematologica, 2011
Background The majority of patients diagnosed with thrombotic thrombocytopenic purpura have autoantibodies directed towards the spacer domain of ADAMTS13.Design and Methods In this study we explored the epitope specificity and immunoglobulin class and ...
Wouter Pos   +6 more
doaj   +1 more source

Idiopathic thrombocytopenic purpura induced by nivolumab in a metastatic melanoma patient with elevated PD-1 expression on B cells.

open access: yesAnnals of Oncology, 2016
Nivolumab has shown promising early results in patients with advanced malignancies, including melanoma and lung cancer, with generally manageable side effects.
S. Kanameishi   +5 more
semanticscholar   +1 more source

Current advances 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Elizabeth P. Crowe   +21 more
wiley   +1 more source

Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers

open access: yesBleeding, Thrombosis and Vascular Biology
Immune thrombocytopenia (ITP) is an autoimmune disease that causes a drop in platelet count
Giuseppe Auteri   +3 more
doaj   +1 more source

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

open access: yesNew England Journal of Medicine, 1998
BACKGROUND Thrombotic thrombocytopenic purpura is a potentially fatal disease characterized by widespread platelet thrombi in the microcirculation. In the normal circulation, von Willebrand factor is cleaved by a plasma protease.
H. Tsai, E. Lian
semanticscholar   +1 more source

Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery

open access: yes
American Journal of Hematology, Volume 100, Issue 7, Page 1234-1239, July 2025.
Sebastian Vuong   +3 more
wiley   +1 more source

Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil

open access: yesHematology, Transfusion and Cell Therapy, 2018
Background: Several studies have demonstrated that platelet counts in Helicobacter pylori-positive patients with chronic idiopathic thrombocytopenic purpura improved significantly after successful eradication of the infection.
Alzira Maria de Castro Barbosa   +6 more
doaj  

Home - About - Disclaimer - Privacy